Eur Rev Med Pharmacol Sci 2022; 26 (18): 6787-6795

DOI: 10.26355/eurrev_202209_29780

The importance of vitamin D and omega-3 PUFA supplementation: a nonpharmacologic immunomodulation strategy to halt autoimmunity

M. Infante, A. Fabbri, D. Della-Morte, C. Ricordi

Cell Transplant Center, Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, USA. marco.infante@unicamillus.org


The large, randomized, double-blind, placebo-controlled trial VITAL (Vitamin D and omega 3 trial) recently confirmed that vitamin D and omega-3 polyunsaturated fatty acid (PUFA) co-supplementation (VIDOM) can reduce the incidence of autoimmune diseases. Based on these relevant results, this commentary summarizes the molecular mechanisms behind the anti-inflammatory and immunomodulatory properties of vitamin D and omega-3 PUFAs. We also describe the potential bidirectional interplay between vitamin D metabolism and omega-3 PUFA metabolism that underlies the rationale for VIDOM co-supplementation and that may contribute to enhance the anti-inflammatory and immunomodulatory actions of vitamin D and omega-3 PUFAs when these compounds are administered in combination.

Free PDF Download

To cite this article

M. Infante, A. Fabbri, D. Della-Morte, C. Ricordi
The importance of vitamin D and omega-3 PUFA supplementation: a nonpharmacologic immunomodulation strategy to halt autoimmunity

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 18
Pages: 6787-6795
DOI: 10.26355/eurrev_202209_29780